GPCR
$33.94
Revenue | $0Mn |
Net Profits | $-33.98Mn |
Net Profit Margins | -Inf% |
Structure Therapeutics, Inc.’s revenue jumped NaN% since last year same period to $0Mn in the Q3 2024. On a quarterly growth basis, Structure Therapeutics, Inc. has generated NaN% jump in its revenue since last 3-months.
Structure Therapeutics, Inc.’s net profit fell -42.39% since last year same period to $-33.98Mn in the Q3 2024. On a quarterly growth basis, Structure Therapeutics, Inc. has generated -30.51% fall in its net profits since last 3-months.
Structure Therapeutics, Inc.’s net profit margin jumped NaN% since last year same period to -Inf% in the Q3 2024. On a quarterly growth basis, Structure Therapeutics, Inc. has generated NaN% jump in its net profit margins since last 3-months.
EPS Estimate Current Quarter | -0.19 |
EPS Estimate Current Year | -0.19 |
Structure Therapeutics, Inc.’s earning per share (EPS) estimates for the current quarter stand at -0.19 - a 17.02% jump from last quarter’s estimates.
Structure Therapeutics, Inc.’s earning per share (EPS) estimates for the current year stand at -0.19.
Earning Per Share (EPS) | -0.2 |
Structure Therapeutics, Inc.’s earning per share (EPS) jumped 67.74% since last year same period to -0.2 in the Q3 2024. This indicates that the Structure Therapeutics, Inc. has generated 67.74% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Date | Estimated EPS | Reported EPS | Surprise % |
---|---|---|---|
2024-05-09 | -0.21 | -0.19 | 9.52% |
2024-11-13 | -0.19 | -0.2 | -7.12% |
2024-08-08 | -0.23 | -0.18 | 20% |